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This meeting was held in Bologna, Italy, a city that houses the oldest 
University in the world (1088). It was not only the Congress of the 
World Section, it also included the Annual Meetings of the Australasian, 
European, Japanese and North American sections, which were hosted 
in equally prestigious Universities in Italy, namely Padua and Ferrara, 
from 20 to 22 June.
Almost 2 000 delegates and guests came to learn more about all 
matters relating to the heart from Cell to Man to Society.  A very dense 
program from 8 am till 9 pm was organized in 5 plenary sessions, 
56 Frontier symposia, 4 Nobel Laureates and landmark scientifi c 
evening lectures, and more than 700 posters. The South African 
delegation was represented by 9 researchers (11 posters presentations 
and 2 talks). 
Although South Africa belongs to the European section of the ISHR, I 
elected to attend the American Section meeting that was held prior to 
the World Meeting in the old Santa Lucia church in Bologna. At that 
meeting, I was particularly interested in a a session on sphingosine 1 
phosphate (S1P) and the heart. S1P is a constituent of the HDL particle 
and is responsible for part of the nitric oxide–mediated vasodilatory 
effect of HDL. In this session, Prof J Heller Brown, Prof J Karliner and 
Dr Levkau discussed the potential protective role of various activated 
S1P receptors isoforms against ischemia-reperfusion. A rapid elevation 
of S1P-containing HDL plasma levels may be a future therapeutic 
approach in patients at high risk of acute myocardial infarction.
At the world meeting, various topics were covered with several full 
sessions on the metabolic syndrome. Prof Yusuf stressed the fact that 
metabolic syndrome is not a genetic disease but a man-made disease. 
A novel protein kinase seems to emerge as an important signalling 
molecule in the heart. Protein kinase D, previously described as protein 
kinase Cμ has emerging myocardial functions such as the control of 
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cellular growth and survival and, more recently, its role as a regulator of 
cardiac gene expression (Dr McKinsey) and contractile function (Prof 
Avkiran).  
Several sessions focused on the protection against myocardial ischemia 
and reperfusion, with particular emphasis on the recently discovered 
phenomenon of ischemic postconditioning, whereby small episodes of 
ischemia-reperfusion, administered immediately upon revascularisation, 
can protect the heart against reperfusion injury. Understanding the 
protective pathways involved in this very promising therapy may lead to 
the development of novel drug therapies to limit cell death in coronary 
heart disease. Some of the work that we presented at the meeting was 
related to the critical role of the immune system as a mediator in 
ischemic postconditioning. Interestingly, we have shown that mice 
defi cient in the cytokine tumor necrosis factor (TNF) failed to be 
protected with ischemic postconditioning, therefore suggesting that 
activation of TNF is required for ischemic postconditioning to protect 
the heart. We also demonstrated that the protective effect of ischemic 
postconditioning seemed to be dependent on age, as older mice failed 
to be protected. 
Meeting abstracts have been published in Journal Molecular and Cellular 
Cardiology, June 2007, volume 42, Supplement 1 and are available 
online at http://www.sciencedirect.com/science/journal/00222828.
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